The cellular Brn-3a transcription factor is known to activate transcription of the genes encoding the human papilloma virus E6 and E7 proteins and is over-expressed in women with cervical neoplasia. We show that cervical cell lines with reduced Brn-3a expression show a greatly reduced ability to form tumours in nude mice compared to control cells and also show reduced expression of the HPV E6 and cellular Bcl-2 oncogenes. These eects are also observed in cervical cells over-expressing the related Brn-3b factor, which is known to antagonize activation of HPV gene expression by Brn-3a. These results demonstrate, for the ®rst time, that inhibition of Brn3a expression or enhanced Brn-3b expression can inhibit cervical cell-derived tumour growth in vivo as well as in vitro. Hence they establish Brn-3a as a key factor in cervical tumorigenesis and as a potential therapeutic target in human cervical neoplasia. Oncogene (2001) 20, 4899 ± 4903.
Women with cervical cancer show very high frequency of infection with the human papilloma viruses Type 16 and 18 (Durst et al., 1983; Meanwell, 1987; Schiman et al., 1983) . These viruses produce oncogenic proteins E6 and E7 which are capable of transforming cells to a malignant phenotype and it is now generally accepted that the production of these proteins by HPV-16 or HPV-18 results in cervical cancer. However, infection with both HPV-16 and HPV-18 can be detected in women with no cervical abnormality (Burghardt, 1984; Cox et al., 1986) . Moreover, most infections with HPV-16 or HPV-18 in young women are of short duration with median clearance times of approximately 1 year with long term persistence of the virus being associated with signi®cant risk of progression to cancerous lesions such as cervical intraepithelial neoplasia type 3 (CIN3) (Nobbenhuis et al., 1999) .
It is therefore likely that cellular factors regulate HPV-16 and HPV-18 in infected cells so as to determine whether these cells become transformed to a malignant phenotype. One such potential mechanism involves a natural polymorphism in the p53 tumour suppressor protein, which determines whether it is eciently degraded by the E6 HPV protein. Thus it has been suggested that individuals whose p53 is more rapidly degraded by E6 would have a higher risk of cervical cancer following HPV infection (Storey et al., 1998) although other studies have suggested that this is not the case (van Duin et al., 2000) .
Another potential mechanism for regulating transformation by HPV would be by controlling the expression of the E6 and E7 proteins, rather than by regulation of their activity. In this regard, we have previously demonstrated that the cellular POU family transcription factor Brn-3a (for review of POU factors see Verrijzer and van der Vliet, 1993) binds to an ATGCAATT motif in the upstream regulatory region (URR) of the HPV genome which controls the transcription of the E6 and E7 genes and strongly activates transcription (Morris et al., 1994) . Conversely, the related POU family transcription factor Brn3b also binds to this motif but represses URR-driven transcription (Morris et al., 1994) .
Interestingly, although originally identi®ed as neuronally expressed transcription factors (Gerrero et al., 1993; Lillycrop et al., 1992) both Brn-3a and Brn-3b have been shown to be expressed in cervical cells (Lillycrop et al., 1992) . This raises the possibility that alterations in the level of Brn-3a or Brn-3b in dierent individuals may play a role in the progression of cervical cancer following initial HPV infection. Indeed, we showed that Brn-3a levels are elevated approximately 300-fold in cervical material from women with cervical intra-epithelial neoplasia 3 (CIN3) compared to similar material from women without detectable cervical abnormality (Ndisang et al., 1998) . Conversely, Brn-3b levels were similar in the two groups resulting in a greatly elevated ratio of the level of the Brn-3a activator of URR-driven transcription compared to the Brn-3b repressor in the women with CIN3 (Ndisang et al., 1998) .
Interestingly, in a subsequent study (Ndisang et al., 2000) we demonstrated that Brn-3a levels were elevated throughout the cervix in the women with CIN3, rather than simply being elevated in the area of the lesion. This indicates that the elevated levels of Brn-3a are not a consequence of transformation itself. Rather, it is likely that individuals with elevated Brn-3a levels produced by either genetic or environmental eects are at elevated risk of cervical cancer. Thus following an initial HPV infection, the elevated levels of Brn-3a in such individuals would induce high levels of E6 and E7 production, resulting in oncogenic transformation at the transformation zone at the junction of the ectoand endo-cervix where HPV and cervical tumours are localized.
Evidently, this idea suggests that Brn-3a plays a critical role in elevating HPV gene transcription in cervical cells and thereby producing cervical transformation. In experiments to test this possibility, we produced stably transfected SiHa cell lines in which the expression of Brn-3a had been arti®cially reduced using an anti-sense approach . These cells showed dramatically reduced levels of HPV E6 gene expression, compared to control cells transfected with plasmid vector alone. The cells also showed reduced rates of cell growth, decreased saturation density and, unlike control cells, were unable to grow in an anchorage independent manner in soft agar. All these growth eects were dependent on the reduced HPV gene expression in these manipulated SiHa cells since they were not observed when Brn-3a levels were reduced using the same approach in C-33 cervical cells which are not transformed by HPV .
Although the ability to grow in an anchorage independent manner, is considered to be predictive of the ability to form tumours in vivo, our previous experiments have only directly tested the eect of manipulating Brn-3a on tumour cell growth in vitro.
To assess the ability of the cells with the reduced Brn-3a levels to form tumours in vivo, the SiHa-derived clones stably transfected with an anti-sense Brn-3a plasmid were injected into nude mice and growth assessed by measuring the size of the tumour at regular intervals. SiHa cells stably transfected with the control plasmid lacking any Brn-3a insert were similarly injected for comparison.
As illustrated in Figure 1 , the control SiHa cells showed rapid tumour growth in the nude mice which was observed in all six animals injected and by approximately 8 weeks after injection, several animals had to be killed due to the size of the tumour formed. In contrast, in the animals injected with the anti-sense ) formed by control SiHa cells (diamonds) at the indicated day after inoculation is compared to that of SiHa cells with reduced Brn-3a levels (triangles) or enhanced Brn-3b levels (squares). The SiHa-derived cell lines were used in a xenograft model by inoculation in the¯anks of female nude mice, which were 2 ± 3 months old and weighed 20 ± 25 g at initiation of experiments. Subsequent passaging was by s.c. implantation of small tumour pieces (approx. 1 mm 3 ), using six mice per group. Mice were given food and water ad libitum. All experiments were in compliance with the UKCCCR Guidelines for the Welfare of Animals in Experimental Neoplasia. Tumours were measured on every third or fourth day, and the mice culled when the volume exceeded 1.5 cm 3 . Data are the means and s.e. of six mice per group, plotted until only four mice remained in a group Brn-3a regulates cervical tumour growth D Ndisang et al
Brn-3a cells no growth was observed in any animals for at least 6 weeks after injection. Subsequently, very limited growth of tumours was observed in three of the animals in this group with no growth at all in the other three animals. Similar reduced growth was also observed with the Brn-3a anti-sense clones in a subsequent experiment involving injection of six mice with each type of cell (data not shown). Moreover, we also observed reduced tumour formation in vivo with SiHa cells stably over-expressing the Brn-3b repressor of HPV gene expression (Figure 1 ). This parallels the reduced HPV gene expression, cellular growth in vitro and anchorage independence observed with Brn-3b over-expressing cells in culture in our previous experiments . Hence, the Brn-3a anti-sense cells do indeed show a reduced ability to form tumours in vivo paralleling their reduced growth rate and anchorage independence in vitro. Indeed, the eect of reduced Brn-3a levels on tumour growth rate in vivo (Figure 1 ) was more dramatic than the eect on in vitro growth rate which we previously observed suggesting that the eect of reducing Brn-3a levels is magni®ed under in vivo growth conditions. To con®rm that this eect was due to changes in HPV gene expression in the tumour cells in vivo, we prepared RNA from the small tumours formed by the anti-sense cells and from the much larger tumours formed by control cells. As in our previous experiments, we then carried out a reverse transcriptase/polymerase chain reaction (RT ± PCR) assay to measure the levels of Brn-3a, Brn-3b and E6 mRNAs in the tumour material. In all cases, the amount of ampli®ed product was measured at a number of dierent PCR cycles to ensure that quantitation was carried out in the linear phase of the assay. We have previously demonstrated that this is an eective method of accurately measuring these mRNAs in small amounts of tumour material (Ndisang et al., 1998 (Ndisang et al., , 2000 . In each case, the samples were equalized by measuring the level of the control mRNA encoding cyclophilin so as to ensure that any dierences observed were not due to the amount of RNA obtained from each tumour.
As illustrated in Figure 2 , the tumours grown from the anti-sense transfected cells showed a clear reduction in Brn-3a and HPV mRNA levels compared to the Figure 2 Expression of the Brn-3a, Brn-3b, E6 and Bcl-2 mRNAs in control Siha cells (Siha), Siha cells with reduced Brn-3a (-3a) or Siha cells over-expressing Brn-3b (3b) grown either in vitro or in nude mice in vivo. The`T' pre®x indicates the results obtained from tumours produced in vivo whilst the remaining bars indicate the results for the same cells grown in vitro. Values are the mean of three independent determinations whose standard error is indicated by the bars. RNA was prepared using the guanidinium isothiocyanate method as previously described (Ndisang et al., 1998 . In brief, the recovered tumours were sliced in small sections and about 40 mg was homogenized in 250 ul solution containing 4 M guanidinium thiocyanate, 25 mM sodium citrate pH 7.0, 0.1 M 2-mercaptoethanol and 0.5% N-laurolsarcosine. The resultant RNA samples were treated with 250 mg/ml DNase. A 1 ul aliquot (0.1 ug/ul) of RNA was then used as template for cDNA synthesis. The synthesized cDNA was used in RT ± PCR assays with the respective Brn-3a, Brn-3b, HPV-16 E6 and cyclophilin oligonucleotide primers as previously described , though the following additional forward and reverse Bcl-2 primers were included in this case: forward, CTACTCCCTGGGAGAGCT and reverse, GGAAACTTAGCCATCGGATA. In all cases, 20 ul of each PCR product was fractioned on a 2% agarose gel and blotted onto Hybond-N + nylon membrane (Amersham, UK) which was then hybridized at 658C overnight with homologous complimentary 32 P-labelled probes. The membranes were exposed to ®lms (Eastman Kodak Co.), and the subsequent autoradiographs were then analysed using a densitometer (Bio-Rad Lab, Hercules) as previously described (Ndisang et al., 1998 levels observed in the tumours formed by control SiHa cells transfected with plasmid vector alone. This parallels the reduced Brn-3a and HPV mRNA levels observed in the anti-sense cells growing in vitro compared to control cells growing in vitro, although interestingly, a more dramatic reduction of Brn-3a and E6 mRNA levels was observed in vivo compared to in vitro (Figure 2 and Ndisang et al., 1999) paralleling the more dramatic eect on in vivo growth observed in the anti-sense cells. In contrast, as expected, levels of Brn3b were unchanged in the cells with reduced expression of Brn-3a both in vitro and in vivo (Figure 2) .
Hence, the dierences in Brn-3a and HPV gene expression, which are observed in the dierent cells growing in vitro, are observed even more strongly under in vivo growth conditions. Thus reduced Brn-3a levels result in reduced HPV gene expression in vivo as well as in vitro producing the observed dramatic reduction in tumour cell growth in the cells transfected with anti-sense Brn-3a, compared to control cells.
Interestingly, we also observed reduced HPV E6-expression in the tumours grown from SiHa cells overexpressing Brn-3b (Figure 2 ). This parallels the reduced level of E6 observed in these cells in vitro as well as the known ability of Brn-3b to repress the HPV promoter in co-transfection assays (Morris et al., 1994) suggesting a direct eect of Brn-3b on HPV gene expression and tumour growth. However, the increased Brn-3b in these cells also produced decreased Brn-3a both in vitro and more dramatically in vivo (Figure 2 ). This is consistent with an inhibitory eect of Brn-3b on the Brn-3a promoter and indicates that raised Brn-3b levels may inhibit HPV gene expression and tumour growth by acting indirectly via decreased Brn-3a expression. Hence, both inhibition of Brn-3a expression or overexpression of Brn-3b (acting directly or indirectly) result in inhibition of HPV gene expression and tumour cell growth both in vitro and in vivo.
In parallel with measuring viral gene expression, in these experiments we also measured the levels of the mRNA encoding the cellular Bcl-2 oncogene protein in the dierent cell types. This has not previously been done in these cells growing either in vitro or in vivo. This was done since we have previously shown that over-expression of Brn-3a can activate the Bcl-2 gene promoter and result in enhanced Bcl-2 gene expression in neuronal cells (Smith et al., 1998a,b) . In these experiments (Figure 2) we did indeed observe that the anti-sense cells showed greatly reduced levels of Bcl-2 mRNA compared to the control cells both in cultured cells growing in vitro and tumours growing in vivo. Hence manipulation of Brn-3a levels can aect not only HPV gene expression but also the expression of a cellular target gene which is known to play a key role in preventing programmed cell death (apoptosis). Brn3b over-expressing cells also showed greatly reduced Bcl-2 mRNA levels when growing in vitro and in vivo.
These data indicate therefore that reduction of Brn3a levels or enhanced Brn-3b levels can have signi®cant eects on both HPV and cellular gene expression in cervical tumour cells and can produce a dramatic reduction in the ability of such cells to grow in vitro and more importantly, upon their ability to form tumours in vivo. They therefore support the hypothesis (Ndisang et al., 1998) that the greatly elevated levels of Brn-3a in women with CIN3 play a key role in the enhanced HPV gene expression and abnormal cervical cell growth which is observed in these women. It will therefore be of particular interest, to determine, for example, whether elevated Brn-3a levels are associated with an enhanced risk of tumour development in young women under the age of 30 where the majority of HPV infections resolve within 1 year with persistence of HPV being strongly associated with tumour formation (Nobbenhuis et al., 1999) . Similarly, it will be of importance to determine whether tumour formation and growth by unmanipulated SiHa cells in nude mice can be aected by reduction of Brn-3a levels using a viral vector expressing the anti-sense strand of Brn-3a. If the growth of an established growing tumour can indeed be manipulated by reducing Brn3a levels, this would have potential therapeutic application if pharmacological or gene therapy procedures could be developed to arti®cially lower Brn-3a levels in human cervical tumours.
